RWE, Market Access, Pricing & Reimbursement Global Congress 2021 Europe

Days
Hours
Minutes
Seconds

7th - 8th October 2021 - 2 Day Conference
London, UK

Apply To Speak
Exhibit & Sponsor Opportunities
Venue

Hilton London Kensington, London, UK

Address

179-199 Holland Park Ave, London W11 4UL, UK

Phone

+44 (0) 207 193 3485

RWE, Market Access, Pricing & Reimbursement

Global Congress 2021 Europe

On a global scale, the pharmaceutical market is expected to grow in the years to come regardless of the recent slowdown in key markets across the globe. The increase is exacerbated by the growing and ageing population in key markets. Aside from this, increasing access to Pharmaceuticals to poor and middle-class families due to increases in disposable income also driving the growth of the industry. Pharma companies focusing on Rare and specialty medicines is another aspect leading the growth. Innovations attracting investments even from non-pharma companies are also sustaining the growth in the pharmaceutical industry.

The pharmaceutical industry is one of the major players in the healthcare sector. Governments across Europe are struggling to balance the desire to provide timely access to innovative medicines with the need to contain healthcare spending due to the increasing pressure between the demands of the EU, national governments, and regional authorities.

Read Full Introduction
Insights & Attendees

Featuring Key Industry Experts

Speaker 1

Awaiting for photo and bio - Senior Representative

Speaker 2

Awaiting for photo and bio - Senior Representative

Speaker 3

Awaiting for photo and bio - Senior Representative

Speaker 4

Awaiting for photo and bio - Senior Representative

All Expert Speakers

Co-located with

The 8th RWE, Market Access, Pricing & Reimbursement 2021 Europe, will be Co-located Expanded Access Programmes Global Congress 2021 Europe.  

Joint Networking at the Exhibit area.

Take advantage of networking with attendees and participants with receptive mindsets, from both events.

To find out about the range of branding, Exhibit, and Sponsorship Options, get in touch. 

Exhibit & Sponsor Opportunities
Scroll to Top

Dear Colleagues,

On a global scale, the pharmaceutical market is expected to grow in the years to come regardless of a recent slowdown in key markets across the globe. The increase is exacerbated by the growing and ageing population in key markets. Aside from this, increasing access to Pharmaceuticals to poor and middle-class families due to increases in disposable income also drives the industry’s growth. Pharma companies focusing on Rare and speciality medicines is another aspect leading the growth. Innovations attracting investments even from non-pharma companies are also sustaining the growth in the pharmaceutical industry.

The pharmaceutical industry is one of the major players in the healthcare sector. Payers want to provide access and fund innovative treatments to improve patient care but governments across Europe are struggling to balance the desire to provide timely access to innovative medicines with the need to contain healthcare spending due to the increasing pressure between the demands of the EU, national governments and regional authorities.

As healthcare budgets are continuously rising in Europe, governments implement a wide variety of policies to control them with the help of different public regulatory bodies that are involved in pharmaceutical coverage decisions across Europe. International collaboration among HTA and regulatory bodies can promote knowledge exchange, as do the actions payers take in an effort to reduce costs while maintaining quality care.

The upcoming 2021 RWE, Market Access, Pricing and Reimbursement Global Congress Europe will present a dynamic approach to key trends and insights on market access, health
technology assessment, real-world data, patient access, pricing and reimbursement on the current European landscape.

This year, we are putting together an agenda that addresses “A New Model of Access Strategy for the Next Normal.”. We are gathering together high calibre expert speakers to participate and share their knowledge and expertise through Keynote Presentations and Panel discussions, addressing all aspects of the industry.

We look forward to welcoming you to the RWE, MAPR 2021 congress!

Sincerely yours,

Jocelyn Raguindin
Jocelyn Raguindin

Jocelyn is Conference Director at Paradigm Global Events (PGE). She has over 15+ years experience in organizing pharma-industry conferences and has been at the helm of every PGE conference since 2013. Jocelyn is based in London, UK.

Why you should attend:

  • Take part in meaningful discussions with industry experts and key decision-makers on current trends and best practices
  • Realise the potential of RWE to achieve launch success and optimal market access
  • Learn from your peers about pricing and reimbursement systems in their market
  • Know how to implement a successful market access strategy and how to communicate value to stakeholders
  • Recognise the importance of innovative real-world evidence partnerships for better data
  • Hear an overview of the market access system in place in large pharma markets
  • Gain knowledge of the Market Access environment in Europe’s major markets
  • Find out the role of emerging markets
  • Challenges and opportunities in pricing, reimbursement and patient access
  • Global and European MA trends, collaboration and spillovers
  • Payer & industry perspective for better access
  • Patient-centred approach for better outcome

You Will Meet:

Network with members of boards, VP’s, Directors, Heads/Chiefs and Senior Managers of leading biopharmaceutical and biotech companies, government, CRO and solution providers involved in:

  • Market Access
  • Reimbursement
  • Patient Outcomes
  • Drug Pricing
  • Health Economics and Outcomes Research
  • Payer Relations/ Evidence
  • Regulatory Affairs
  • Public / Government Affairs
  • Payers, HTA Officials and Physicians
  • Business Development
  • Marketing
  • Commercial Executives
  • Product Launch
  • Real World Evidence
  • Commercialisation
  • Value Strategy
  • Product Strategy
  • Forecaster
  • Finance Officer

Robert Donnell

Head of Business Development at Durbin PLC

Robert Donnell has 20 years’ experience in the pharmaceutical sector, working for large blue-chip companies such as Procter & Gamble and AstraZeneca.Robert joined Durbin, one of the world’s leading specialist Comparator and Clinical Trials Supply companies in 2009. He is responsible for global business development across the Durbin Group, including developing relationships and devising strategic partnerships with multinational pharmaceutical and biotechnology companies.Robert has advised several UK Members of Parliament on Healthcare policy and lectures extensively on Global supply issues.

Lisa Deck

Founder and Director of Sisters@Heart

Lisa Deck is a Founder & Director of Sisters@Heart, a non-profit organization that improves the lives of those affected by heart disease and stroke.  Lisa is a former Go Red for Women National Spokeswomen for the American Heart Association and currently serves as an Advocacy Board Member for the American Heart Association in Boston and Southern New England.  

Suffering her first three strokes twenty years ago, Lisa has been a patient activist and international speaker for the past two decades.   Lisa lobbies at the local, state and Federal level for health and awareness policy development. She is a widely known advocate voice that inspires others and raises awareness of heart disease, stroke and Moyamoya disease.

In 2015, Lisa was diagnosed with Moyamoya Disease, a rare cerebrovascular disease, after an 18-year diagnostic odyssey. She underwent two brain bypass surgeries to restore blood flow to her brain.  Since then, Lisa has become actively involved in rare disease advocacy, serving as a Committee member of Rare New England. Rare New England brings together New England patients, families and providers touched by rare and complex disorders.  On behalf of Rare New England, Lisa produces and hosts a local cable show, The World of Rare Disease.  Lisa is also active with the newly formed Moyamoya Foundation.  Lisa lives in North Attleboro, MA with her husband and two children.